Pathogenic variants in CLRN1 have been linked to variable clinical outcomes, ranging from non-syndromic RP (Khan et al. 2011) to USH3A characterized by variable and progressive post-lingual hearing loss, RP, and variable vestibular responses (Plantinga et al. 2005). This evidence concerns the gene CLRN1 and retinitis pigmentosa 1.